Gujarat Terce Laboratories Peer Comparison

Gujarat Terce Laboratories Ltd. exhibits poor financial performance with no growth metrics, negative PE ratio, and no returns on equity or assets, making it a weak contender in the Pharmaceuticals & Drugs sector. In contrast, peers like Sun Pharmaceutical Industries and Cipla demonstrate strong profitability and growth, highlighting Gujarat Terce's underperformance and financial distress.

• • Gujarat Terce Laboratories shows no revenue growth and negative PE, indicating financial distress.
• • Top peers like Sun Pharma and Cipla exhibit strong revenue growth and profitability metrics.
• • Value picks identified as those with low PE and high ROE, contrasting with Gujarat's financial weaknesses.

• • Cipla Ltd.: Strong revenue growth (13.28% YoY), robust ROE (16.63%), and a reasonable PE (23.73) indicate high profitability.
• • Sun Pharmaceutical Industries Ltd.: High profitability with a ROE of 16.13% and strong revenue growth (8.42% YoY) despite a high PE ratio.
• • Dr. Reddy's Laboratories Ltd.: Solid revenue growth (16.54% YoY) and a strong ROE (21.76%) with a low PE ratio (15.50) make it attractive.